Open AccessTreatment of chronic viral hepatitis C in the female patient with mucinous adenocarcinoma of the pancreas
Author(s) -
Viktorijo Borisovna Poluektova,
E. V Volchkova,
П. И. Давыденко,
Ekaterina Mihaylovna Fillipova
Publication year - 2014
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid40813
Subject(s) - pancreas , medicine , malignancy , chemotherapy , gastroenterology , chronic hepatitis , adenocarcinoma , abdomen , oncology , radiology , cancer , immunology , virus
When planning the antiviral therapy (AVT) in patients with chronic gastrointestinal diseases in a history, a number ofadditional factors should be taken into account. In particular, at the start of the AVT it can be possible the activation of hidden malignancy occurring before. At the same time, the management of such patients at the background of the start of AVT in HCV cases has not practically developed. We have seen the female HCV patient with the cyst of the pancreas. Antiviral therapy has triggered the development of the abdominal pain syndrome. Additional tests: CT, endoultrasound, MRT of the abdomen revealed a colloidal adenocarcinoma of the tail of the pancreas. Removal of the tumour, 6 courses of chemotherapy and the absence of its relapses allowed to start and successfully carry out the AVT for HCV. The taken tactics of the patient and the used drugs well constrained the process of the reactivation of the tumour of the pancreas during therapy and for 4 months after the its accomplishment.